Establishment of a Real-Time Recombinase Polymerase Amplification for Rapid Detection of Pathogenic Yersinia

Hongjian Zhang1, Meng Zhao1, Siyun Hu1

  • 1College of Agriculture and Animal Husbandry, Qinghai University, Xi'ning 810016, China.

Insights

A new real-time recombinase polymerase amplification (RPA) assay rapidly detects pathogenic Yersinia enterocolitica using the ail gene. This sensitive method offers a faster alternative for early pathogen diagnosis.

Area of Science:

  • Microbiology
  • Molecular Biology
  • Diagnostic Assays

Background:

  • Yersinia enterocolitica is a globally prevalent zoonotic bacterium causing various illnesses, from self-limiting infections to severe sepsis.
  • Accurate and rapid detection is crucial for managing Yersinia enterocolitica infections and preventing severe outcomes.

Purpose of the Study:

  • To develop a rapid and sensitive real-time recombinase polymerase amplification (RPA) assay for the detection of pathogenic Yersinia enterocolitica.
  • To establish an assay based on the conserved ail gene for improved specificity.

Main Methods:

  • Development of a real-time RPA assay targeting the ail gene of Yersinia enterocolitica.
  • Optimization of reaction conditions, including primers and Exo probe, for isothermal amplification at 38 °C.
  • Evaluation of assay sensitivity and specificity using known concentrations of genomic DNA and DNA from other pathogens.

Main Results:

  • The real-time RPA assay successfully detected Yersinia enterocolitica within 20 minutes at a constant temperature of 38 °C.
  • The assay demonstrated high sensitivity, with a detection limit of 10⁻⁴ ng/μL.
  • The assay showed high specificity, yielding negative results with genomic DNA from other common pathogens.

Conclusions:

  • A rapid, sensitive, and specific real-time RPA method for detecting pathogenic Yersinia enterocolitica has been successfully established.
  • This assay provides a valuable tool for the early diagnosis of Yersinia enterocolitica infections, potentially improving patient outcomes.
  • The optimized assay offers a significant advancement in pathogen detection technology.